• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

Medical News Interviews

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Audio Journal of Oncology with Oncology Times, June 2013

0
  • by alexperjescuadmin
  • in Oncology
  • — 13 Jun, 2013
Lugano

LUGANO, SWITZERLAND—Sarah Maxwell and Peter Goodwin report from the 2013 European Multidisciplinary Conference on Thoracic Oncology:

Biomarkers: new drug targets in adenocarcinoma of the lung
Professor Ken O’Byrne, St James’s Hospital and Trinity College, Dublin.

Emerging targetable biomarkers for squamous cell carcinoma
Dr Martin Edelman, University of Maryland School of Medicine, Baltimore.

Centrally located tumors: control vs. toxicity
Dr Suresh Senan, VU University Medical Center, Amsterdam.

Tailored chemo-radiotherapy: maximize effect; minimize tissue damage
Dirk De Ruysscher, Maastricht University Medical Center, Netherlands.

PET-CT guidance for treating nodules helps avoid overtreatment
Dr Barbara Malene Fischer, Copenhagen University.

Immune therapies restore tissue immunity to fight cancer
Professor Martin Reck, Grosshansdorf Hospital, Hamburg

Share

You may also like...

  • ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando ASCO Audio Journal of Oncology in Advance – February 1st, 2007 – reporting from American Society of Hematology 48th Annual Meeting, December 9-12, 2006 Orlando 3 Feb, 2007
  • ASCO Audio Journal of Oncology – July 1st 2006 ASCO Audio Journal of Oncology – July 1st 2006 30 Jun, 2006
  • Bivalent Vaccine for HPV: Interim Phases III Data Show High Efficacy Bivalent Vaccine for HPV: Interim Phases III Data Show High Efficacy 2 Aug, 2007
  • John Mendelsohn The WIN consortium meets in Paris – a boost for cancer science 17 Jul, 2013

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Breast cancer chemoprevention: meta-analysis shows SERMs are highly effective
  • Next story MEK-inhibitor selumetinib doubles progression free survival in advanced uveal melanoma
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Which New Combination for Metastatic Renal Cell Cancer?
    • CT Screening Cuts Lung Cancer Deaths 24 Per…
    • Lung Cancer: Geriatric Assessment Before Concurrent…
  • Home
  • Oncology
  • Audio Journal of Oncology with Oncology Times, June 2013

© Copyright 2021 AudioMedica.com. Typegrid Theme by WPBandit.